Key facts
- It has raised $43.7M; the latest was Later Stage VC ($13.7M) in Apr 2025.
- Notable investors include Y.R.Delta Fund, Jinan International Medical Center Industrial Development, Changshu Development and Investment, Poly (Hengqin) Capital Management, Qilu Finance Investment — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Aopeng Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Aopeng Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aopeng Medical
Developer and provider of medical robotics intended for vascular interventional surgery. The company engages in the research and development of advanced vascular interventional surgery robots with artificial intelligence and 5G technology to be widely applied in interventional surgeries including coronary intervention, neuro-intervention, tumor intervention and etc., improving the success rate of surgical operations.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2017
- Website
- operaterobot.com/
- Ownership
- Privately Held (backing)
Aopeng Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aopeng Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aopeng Medical in its N-PORT filings yet. We sweep new filings monthly.